India's Wockhardt up 20% on antibiotic drug's success

Wockhardt

01/07/2024 08:53

** Shares of pharma and biotech co Wockhardt  WCKH.NS  rise an
exchange-allowed maximum of 20% to 823.9 rupees 
    ** Co said its antibiotic drug Zaynich successfully treated
a cancer patient in the U.S. with chronic bilateral thigh
infection 
    ** The U.S. Clinical and Laboratory Standards Institutes
(CLSI) grants high susceptibility breakpoint to the drug on its
success 
    ** Susceptibility breakpoint is a key metric for doctors to
recognize most effective antibiotics 
    ** Stock eyes busiest trading session since mid-Feb, over
5.5 mln shares traded 
    ** Including session's gains, stock up ~94% YTD 

 (Reporting by Manvi Pant in Bengaluru)
 ((Manvi.Pant@thomsonreuters.com; +918447554364;))